SCHEMBL31383992

SCHEMBL31383992

CC(OCC(=O)O)c1c(Br)cccc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CD69 Q07108 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ PKM P14618 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ THRA P10827 2/20 0.35
▸ THRB P10828 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PTPN1 P18031 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PTPN7 P35236 1/20 0.33
▸ PTPN12 Q05209 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31383943 0.79 SLC6A2 (0.38) KMT2APKMTSHRHSD17B10MEN1
SCHEMBL16672851 0.74 FFAR1 (0.49) ALOX15KMT2APOLBSMN1; SMN2GLA
SCHEMBL26629385 0.72 ADRA1D (0.36) POLBALDH1A1PKMTSHRTHRA
SCHEMBL9646424 0.68 KMT2A (0.66) LMNAALOX15KMT2ACD69POLB
SCHEMBL9292031 0.68 KDM4E (0.39) LMNAALOX15KMT2ACD69POLB
SCHEMBL29876470 0.68 KDM4E (0.41) POLBSMN1; SMN2L3MBTL1ALDH1A1TSHR
SCHEMBL29143120 0.68 KDM4E (0.41) POLBSMN1; SMN2L3MBTL1ALDH1A1TSHR
SCHEMBL29143124 0.68 KDM4E (0.41) POLBSMN1; SMN2L3MBTL1ALDH1A1TSHR
SCHEMBL24488931 0.68 KMT2A (0.46) LMNAALOX15KMT2APOLBGLA
SCHEMBL22945646 0.68 KMT2A (0.46) LMNAALOX15KMT2APOLBGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064802-A1 INHIBITING HUMAN INTEGRIN α5β1 MORPHIC THERAPEUTIC, INC. (US) 2025-03-27 — — WO disclosed
Send feedback